Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1980-01-04
1981-12-01
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
536 21, A61K 31725, C08B 3710
Patent
active
043036511
ABSTRACT:
Heparin fragments having selective anticoagulation activity having 14-18 sugar units, the disaccharide unit L-iduronosyl-2-O-sulphate-N-sulpho-U-glucosamine-6-O-sulphate being the main component, and where unsulphated L-iduronic acid is in a position situated 3-5 sugar units from the unreducing terminal. Pharmaceutical compositions containing such heparin fragments. Processes for the preparation of the heparin fragments.
REFERENCES:
patent: 3066076 (1962-11-01), Monnier
patent: 3135660 (1964-06-01), Bush et al.
patent: 3810781 (1974-05-01), Eriksson et al.
patent: 3835112 (1974-09-01), Mardiguian et al.
patent: 3891622 (1975-06-01), Mardiguian et al.
Andersson Lars-Olov
Backstrom Gudrun E.
Fransson Lars-Ake
Holmer Erik Y.
Lindahl Ulf P. F.
Brown Johnnie R.
Kabi AB
LandOfFree
Heparin fragments having selective anticoagulation activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin fragments having selective anticoagulation activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin fragments having selective anticoagulation activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1296930